Feed Insights Top Reports Pricing

⌘K

16:20:49·809d

SECFilingvia Quantisnow

SEC Form 10-Q filed by Rezolute Inc.

ByQuantisnow·Wall Street's wire, on your screen.

RZLT· Rezolute Inc.

Health Care

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RZLT (Rezolute Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

RZLT
Rezolute Inc.
Health Care

Recent analyst ratings

Mar 25UpdateWedbush$5.00
Dec 11UpdateCraig Hallum$2.00
Dec 11UpdateCantor Fitzgerald-
Dec 11UpdateWedbush$1.00
Nov 5UpdateWedbush$12.00
Aug 27UpdateGuggenheim$11.00

Related

PR1d
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
PR11d
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
INSIDER32d
SEC Form 4 filed by Evans Daron
SEC37d
Amendment: SEC Form SCHEDULE 13G/A filed by Rezolute Inc.
ANALYST38d
Rezolute upgraded by Wedbush with a new price target
SEC39d
Rezolute Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
PR39d
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
INSIDER59d
Chief Medical Officer Roberts Brian Kenneth covered exercise/tax liability with 11,439 shares, decreasing direct ownership by 4% to 296,913 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022